KATIE EDWARDS: Open Payments
NPI 1508602376 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,012 in 82 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $410 · 2025 $2,012
Food & beverage: $2,012
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 18 | $333 |
| BETA BIONICS, INC. | 2 | $211 |
| UCB, Inc. | 8 | $168 |
| Sequel Med Tech, LLC | 4 | $139 |
| Insulet Corporation | 6 | $136 |
| Radius Health, Inc. | 5 | $123 |
| Abbott Laboratories | 1 | $115 |
| Tandem Diabetes Care, Inc. | 5 | $90 |
| Janssen Biotech, Inc. | 3 | $79 |
| Medtronic, Inc. | 1 | $67 |
Products named: Dexcom G6 Transmitter, iLet Bionic Pancreas, Bimzelx, TWIIST, Omnipod, Tymlos, FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across LA — which companies pay providers there.
